Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 16/20 | 0.44 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.40 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30801496 | 0.90 | ENPEP (0.50) | ENPEPPDCD1LG2CD274ECE1 | |
| SCHEMBL31064946 | 0.87 | ENPEP (0.53) | ENPEPPDCD1LG2CD274ECE1 | |
| SCHEMBL29533659 | 0.82 | ENPEP (0.49) | ENPEPTASP1 | |
| SCHEMBL29695539 | 0.81 | PDCD1LG2 (0.45) | PDCD1LG2CD274ECE1 | |
| SCHEMBL30786582 | 0.81 | ENPEP (0.47) | ENPEPECE1 | |
| SCHEMBL31544014 | 0.80 | PDCD1LG2 (0.41) | PDCD1LG2CD274ECE1 | |
| SCHEMBL29722979 | 0.80 | PDCD1LG2 (0.56) | ENPEPPDCD1LG2CD274ECE1 | |
| SCHEMBL30390488 | 0.80 | ENPEP (0.50) | ENPEP | |
| SCHEMBL29630547 | 0.79 | ENPEP (0.55) | ENPEPECE1 | |
| SCHEMBL7081783 | 0.79 | PDCD1LG2 (0.48) | PDCD1LG2CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | VIP, ARGLU1, PELP1 | ENPEP 56/4885PDCD1LG2 4072/4885CD274 4700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.